...
机译:生物标志性颈部癌症治疗面临的机遇与挑战
Feinstein Institute for Medical Research Manhasset NY United States;
Department of Otolaryngology Hofstra North Shore-Long Island Jewish School of Medicine New Hyde;
Department of Oncology Johns Hopkins University School of Medicine Baltimore MD United States;
Feinstein Institute for Medical Research Manhasset NY United States Department of;
Feinstein Institute for Medical Research Manhasset NY United States Department of;
biomarker; DNA damage repair; epidermal growth factor receptor; functional imaging; head and neck cancer; human papillomavirus; magnetic resonance imaging; microarray; noncoding RNA; personalized therapy; positron-emission tomography; prognosis; radiotherapy; treatment response;
机译:用于个性化头颈癌治疗的生物标志物开发面临的机遇和挑战
机译:使个性化的癌症医学成为现实:生物标志物和伴随诊断技术开发中的挑战和机遇。
机译:使个性化的癌症医学成为现实:生物标志物和伴随诊断技术开发中的挑战和机遇。
机译:图像导向的靶向双光子PDT的开发,用于治疗头颈癌
机译:通过新型研究模型和预后生物标志物改善头颈癌的治疗方法
机译:面临个性化头部颈部癌症治疗的生物标志物开发的机遇与挑战
机译:头部和颈部鳞状细胞癌的MicroRNA:作为生物标志物的可能挑战,用于选择治疗的决定因素和个性化分子疗法的目标